WEP Clinical is a pharmaceutical services company based in Morrisville, North Carolina, founded in 2008. With around 200 employees and generating approximately $67.5 million in revenue, WEP Clinical specializes in supporting drug development and patient access to treatments through a variety of clinical and access programs.

As a full-service Contract Research Organization (CRO), WEP Clinical offers tailored solutions for pharmaceutical sponsors throughout the drug development lifecycle. Their services include managing Expanded Access Programs (EAPs) and Compassionate Use Programs, which provide potentially life-saving treatments to patients with unmet medical needs. They also support clinical trials from pre-clinical stages to commercialization, focusing on patient experience and operational success. Additionally, WEP Clinical provides end-to-end management of drug development programs and market access strategies, ensuring that therapies reach patients efficiently.

WEP Clinical collaborates with pharmaceutical companies, health institutions, and patient advocacy groups to facilitate access to medications, particularly in complex therapeutic areas like oncology and rare diseases. Their commitment to a patient-centric approach and high-quality service distinguishes them in the pharmaceutical services industry.